ClinicalTrials.gg
Active, not recruitingNCT07821463EPIC-PBCUpdated Sep 15, 2026

Epidemiology of PrImary Biliary Cholangitis in Spain

An observational study in PBC and Primary Biliary Cholangitis (PBC), sponsored by Fundacio Privada Mon Clinic Barcelona. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Fundacio Privada Mon Clinic Barcelona · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Study summary

Primary biliary cholangitis (PBC) is a rare, long-term liver disease that can slowly damage the bile ducts, eventually leading to cirrhosis and, in some cases, the need for a liver transplant. The goal of this non-interventional, multi-database study is to characterize the epidemiology of PBC in Spain by estimating its prevalence (cross-sectional study) and incidence (cohort study).The main question it aims to answer is:

  • What is the prevalence of PBC in Spain on a specific index date (31 December 2025)?
  • What is the annual incidence of newly diagnosed PBC in Spain?
  • How many patients with PBC receive first-line and second-line therapies in routine clinical practice?
  • What proportion of patients with PBC develop cirrhosis and/or require liver transplantation, and how long does it take for these events to occur after diagnosis?
  • Which factors are associated with poorer outcomes in patients with PBC?

Researchers will use anonymised information from several large Spanish databases (BIFAP, SIDIAP, the Andalusian PBC Registry and the Spain RDR-Galicia registry) to identify adults with and without PBC and follow them over time.

No patients will be contacted directly or asked to attend any study visits, and no additional tests or treatments will be carried out. All information will come from routinely collected healthcare data on adults with a diagnosis of PBC, which will be fully anonymised before analysis.

02

Conditions studied

  • PBC
  • Primary Biliary Cholangitis (PBC)
03

In context

Liver Cirrhosis, Biliary

214 studies on the registry are indexed under Liver Cirrhosis, Biliary; 48 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 380 across 54 observational studies indexed under Liver Cirrhosis, Biliary.

Browse Liver Cirrhosis, Biliary studies →

Lead sponsor

Fundacio Privada Mon Clinic Barcelona is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults identified in Spanish healthcare databases and registries with a recorded diagnosis of PBC.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Cross-sectional study (Incidence and prevalence of PBC):

    • Individuals aged 18 years included in any of the BIFAPSIDIAP, Galician or Andalusian databases.
  2. Cohort study (Secondary aims):

    • Individuals aged 18 years and older, with PBC and included in any of the SIDIAP, Andalusian, or Galician databases.

Exclusion criteria

Exclusion Criteria:

  • Patients with other causes of liver disease (including, but not limited to, alcohol liver disease, steatotic liver disease, viral hepatitis, etc) will be excluded from the study.
  • Incomplete or invalid records.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
3,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult patients with primary biliary cholangitis (PBC)
06

What researchers measure

Primary outcomes

  1. Epidemiology of PBC in Spain

    To characterize the epidemiology of PBC in Spain by estimating its prevalence (cross-sectional study) and incidence (cohort study).

    Time frame: 15 months

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07821463
Lead sponsor
Fundacio Privada Mon Clinic Barcelona
Responsible party
Sponsor
First posted
Sep 15, 2026
Start date
Feb 11, 2026
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Sep 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion